By using a forward mutation assay at the CAN1 locus (Figure 3A) and reverse mutation assays at the hom3-10 (Figure 3C) locus and lacZ (Figure 3D), the authors demonstrated that 13 out of 27 hMLH1 cancer-associated variants showed a functional impact. This evidence concerns the gene MLH1 and cancer.